Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Fungal infections associated with contaminated methylprednisolone injections.

Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J, Fontaine E, Chu A, Carothers B, Reilly A, Fiedler J, Wiese AD, Feaster C, Gibson L, Griese S, Purfield A, Cleveland AA, Benedict K, Harris JR, Brandt ME, Blau D, Jernigan J, Weber JT, Park BJ; Multistate Fungal Infection Outbreak Response Team.

N Engl J Med. 2013 Oct 24;369(17):1598-609. doi: 10.1056/NEJMoa1213978. Epub 2012 Dec 19.

2.

Clinical findings for fungal infections caused by methylprednisolone injections.

Chiller TM, Roy M, Nguyen D, Guh A, Malani AN, Latham R, Peglow S, Kerkering T, Kaufman D, McFadden J, Collins J, Kainer M, Duwve J, Trump D, Blackmore C, Tan C, Cleveland AA, MacCannell T, Muehlenbachs A, Zaki SR, Brandt ME, Jernigan JA; Multistate Fungal Infection Clinical Investigation Team.

N Engl J Med. 2013 Oct 24;369(17):1610-9. doi: 10.1056/NEJMoa1304879.

3.

Fungal infections associated with contaminated methylprednisolone in Tennessee.

Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, Park BJ, Kanago ML, Baumblatt J, Schaefer MK, Berger BE, Marder EP, Min JY, Dunn JR, Smith RM, Dreyzehner J, Jones TF; Tennessee Fungal Meningitis Investigation Team.

N Engl J Med. 2012 Dec 6;367(23):2194-203. doi: 10.1056/NEJMoa1212972. Epub 2012 Nov 6.

4.
5.

Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections.

Lockhart SR, Pham CD, Gade L, Iqbal N, Scheel CM, Cleveland AA, Whitney AM, Noble-Wang J, Chiller TM, Park BJ, Litvintseva AP, Brandt ME.

J Clin Microbiol. 2013 Aug;51(8):2654-61. doi: 10.1128/JCM.01000-13. Epub 2013 Jun 12.

6.

Fungal infections associated with contaminated methylprednisolone injections.

Kauffman CA, Pappas PG, Patterson TF.

N Engl J Med. 2013 Jun 27;368(26):2495-500. doi: 10.1056/NEJMra1212617. Epub 2012 Oct 19. Review. No abstract available.

7.

Utility of real-time PCR for detection of Exserohilum rostratum in body and tissue fluids during the multistate outbreak of fungal meningitis and other infections.

Gade L, Grgurich DE, Kerkering TM, Brandt ME, Litvintseva AP.

J Clin Microbiol. 2015 Feb;53(2):618-25. doi: 10.1128/JCM.02443-14. Epub 2014 Dec 17.

8.

Spinal and paraspinal infections associated with contaminated methylprednisolone acetate injections - Michigan, 2012-2013.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 17;62(19):377-81.

9.

Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis.

Andes D, Casadevall A.

Fungal Genet Biol. 2013 Dec;61:143-5. doi: 10.1016/j.fgb.2013.08.014. Epub 2013 Sep 6.

PMID:
24012946
10.

Lessons learned in the multistate fungal infection outbreak in the United States.

Pappas PG.

Curr Opin Infect Dis. 2013 Dec;26(6):545-50. doi: 10.1097/QCO.0000000000000013. Review.

PMID:
24152763
11.

Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014.

McCotter OZ, Smith RM, Westercamp M, Kerkering TM, Malani AN, Latham R, Peglow SL, Mody RK, Pappas PG, Chiller TM.

MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1200-1. doi: 10.15585/mmwr.mm6442a4.

12.

Multistate fungal meningitis outbreak -- interim guidance for treatment.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Oct 19;61(41):842.

13.

Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections.

Gade L, Scheel CM, Pham CD, Lindsley MD, Iqbal N, Cleveland AA, Whitney AM, Lockhart SR, Brandt ME, Litvintseva AP.

Eukaryot Cell. 2013 May;12(5):677-83. doi: 10.1128/EC.00046-13. Epub 2013 Mar 1.

14.

Magnetic resonance imaging screening to identify spinal and paraspinal infections associated with injections of contaminated methylprednisolone acetate.

Malani AN, Vandenberg DM, Singal B, Kasotakis M, Koch S, Moudgal V, Jagarlamudi R, Neelakanta A, Otto MH, Halasyamani L, Kaakaji R, Kauffman CA.

JAMA. 2013 Jun 19;309(23):2465-72. doi: 10.1001/jama.2013.6293.

PMID:
23780459
15.

Estimated deaths and illnesses averted during fungal meningitis outbreak associated with contaminated steroid injections, United States, 2012-2013.

Smith RM, Derado G, Wise M, Harris JR, Chiller T, Meltzer MI, Park BJ.

Emerg Infect Dis. 2015 Jun;21(6):933-40. doi: 10.3201/eid2106.141558.

16.

Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections.

Kerkering TM, Grifasi ML, Baffoe-Bonnie AW, Bansal E, Garner DC, Smith JA, Demicco DD, Schleupner CJ, Aldoghaither RA, Savaliya VA.

Ann Intern Med. 2013 Feb 5;158(3):154-61. doi: 10.7326/0003-4819-158-3-201302050-00568. Erratum in: Ann Intern Med. 2013 Mar 19;158(6):504. Dosage error in article text.

PMID:
23183583
17.

Fungal Contamination of Methylprednisolone Causing Recurrent Lumbosacral Intradural Abscess.

Renfrow JJ, Frenkel MB, Hsu W.

Emerg Infect Dis. 2017 Mar;23(3):552-553. doi: 10.3201/eid2303.161334.

18.

Sterile compounding: clinical, legal, and regulatory implications for patient safety.

Qureshi N, Wesolowicz L, Stievater T, Lin AT.

J Manag Care Spec Pharm. 2014 Dec;20(12):1183-91. Review.

19.

Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report.

Nelson G, Fermo O, Thakur K, Felton E, Bang J, Wilson L, Rhee S, Llinas R, Johnson K, Sullivan D.

BMC Res Notes. 2014 May 31;7:327. doi: 10.1186/1756-0500-7-327.

20.

Fungal infections associated with contaminated methylprednisolone injections: review and insights.

Fowler SB, Carothers B.

N J Nurse. 2013 Apr;43(2):12. No abstract available.

PMID:
23617220

Supplemental Content

Support Center